Results 51 to 60 of about 1,253,674 (265)

COVID‐19–associated pulmonary aspergillosis: a prospective single‐center dual case series

Mycoses (Berlin), 2021
COVID‐19–associated pulmonary aspergillosis (CAPA) has emerged as an invasive fungal disease, often affecting previously immunocompetent, mechanically ventilated, intensive care unit (ICU) patients.
Eelco F. J. Meijer, A. Dofferhoff, O. Hoiting, J. Meis   +3 more
semanticscholar   +1 more source

Lung and gut microbiomes in pulmonary aspergillosis: Exploring adjunctive therapies to combat the disease

Frontiers in Immunology, 2022
Species within the Aspergillus spp. cause a wide range of infections in humans, including invasive pulmonary aspergillosis, chronic pulmonary aspergillosis, and allergic bronchopulmonary aspergillosis, and are associated with high mortality rates.
Liuyang Cai, Liuyang Cai, Peigen Gao, Peigen Gao, Zeyu Wang, Zeyu Wang, Chenyang Dai, Chenyang Dai, Ye Ning, Ye Ning, Macit Ilkit, Xiaochun Xue, Jinzhou Xiao, Chang Chen, Chang Chen   +14 more
doaj   +1 more source

Pathogenicity and virulence of Aspergillus fumigatus

Virulence, 2023
Pulmonary infections caused by the mould pathogen Aspergillus fumigatus are a major cause of morbidity and mortality globally. Compromised lung defences arising from immunosuppression, chronic respiratory conditions or more recently, concomitant viral or
Kayleigh Earle, Clara Valero, Daniel P. Conn, George Vere, Peter C. Cook, Michael J. Bromley, Paul Bowyer, Sara Gago   +7 more
doaj   +1 more source

Treatment outcome definitions in chronic pulmonary aspergillosis: a CPAnet consensus statement

European Respiratory Journal, 2022
Chronic pulmonary aspergillosis (CPA) is an uncommon but dreaded complication of many respiratory diseases occurring in non- or mildly immunocompromised patients [1].
E. Van Braeckel, I. Page, J. Davidsen, C. Laursen, R. Agarwal, A. Alastruey‐Izquierdo, A. Barać, J. Cadranel, A. Chakrabarti, O. Cornely, D. Denning, H. Flick, J. Gangneux, C. Godet, Yutaka Hayashi, C. Hennequin, M. Hoenigl, M. Irfan, K. Izumikawa, Won-Jun Koh, C. Kosmidis, C. Lange, B. Lamprecht, F. Laurent, O. Munteanu, R. Oladele, T. Patterson, Akira Watanabe, H. Salzer   +28 more
semanticscholar   +1 more source

Galactomannan-Antigen Testing from Non-Directed Bronchial Lavage for Rapid Detection of Invasive Pulmonary Aspergillosis in Critically Ill Patients: A Proof-of-Concept Study

Diagnostics, 2023
Invasive pulmonary aspergillosis is associated with high mortality. For diagnosis, galactomannan-antigen in serum and bronchoalveolar lavage fluid is recommended, with higher sensitivity in bronchoalveolar lavage fluid.
Kathrin Rothe, Miriam Dibos, Stefanie J. Haschka, Roland M. Schmid, Dirk Busch, Sebastian Rasch, Tobias Lahmer   +6 more
doaj   +1 more source

Aspergillus Lateral Flow Assay with Digital Reader for the Diagnosis of COVID-19-Associated Pulmonary Aspergillosis (CAPA): a Multicenter Study

Journal of Clinical Microbiology, 2021
This multicenter study evaluated the IMMY Aspergillus Galactomannan Lateral Flow Assay (LFA) with automated reader for diagnosis of pulmonary aspergillosis in patients with COVID-19-associated acute respiratory failure (ARF) requiring intensive care unit
B. Autier, J. Prattes, P. White, M. Valerio, M. Machado, Jessica S. Price, M. Egger, J. Gangneux, M. Hoenigl   +8 more
semanticscholar   +1 more source

Peroral amphotericin B polymer nanoparticles lead to comparable or superior in vivo antifungal activity to that of intravenous Ambisome® or Fungizone™

, 2011
Background: Despite advances in the treatment, the morbidity and mortality rate associated with invasive aspergillosis remains unacceptably high (70–90%) in immunocompromised patients.
M N V Ravi Kumar, Sharp Andrew, Jagdishbhai L. Italia, Carter, Katharine C., Carter Katharine C., Kumar, M. N V Ravi, Kumar M. N. V. Ravi, Jagdishbhai L Italia, Italia Jagdishbhai L., Italia, Jagdishbhai L., Katharine C. Carter, M. N. V. Ravi Kumar, Andrew Sharp, Italia, Jagdishbhai L, Kumar, M N V Ravi, Warn, Peter, Warn Peter, Sharp, Andrew, Carter, Katharine C, Katharine C Carter, Peter Warn   +20 more
core   +1 more source

Does Pulmonary Aspergillosis Complicate Coronavirus Disease 2019? [PDF]

, 2020
Objectives:. Aspergillus coinfection in coronavirus disease 2019 patients has rarely been described but may be occurring among coronavirus disease 2019 patients admitted to ICUs.
Karlyn D. Beer, MS, PhD, Paul E. Verweij, MD, PhD, Joost Wauters, MD, PhD, Brendan R. Jackson, MD, MPH, Frank L. Van de Veerdonk, MD, PhD, Tom Chiller, MD, MTMH   +5 more
core   +2 more sources

A pulmonary artery false aneurysm after right middle lobectomy: a case report

, 2007
Pulmonary artery false aneurysm is a rare condition, reported to complicate interventional procedures. We report a case of a false aneurysm of the interlobar pulmonary artery following a right middle lobectomy for lung cancer.
Rao Jagan, Sharma, Hemant, Jagan Rao, Sharma Hemant, Stephen Clark, Shaaban Hossam, Clark Stephen, Shaaban, Hossam, Hossam Shaaban, Hemant Sharma, Rao, Jagan, Clark, Stephen   +11 more
core   +1 more source

Pulmonary Oxalosis in Pulmonary Aspergillosis Syndrome

, 2020
The presence of pulmonary oxalosis in bronchoalveolar lavage (BAL) or biopsied tissue samples is considered pathognomonic for Aspergillus disease etiology.
Oluwasegun Osholowu, Harpreet Singh, Vivek Kak   +2 more
core   +2 more sources